Share this
IN8bio – $40 Million IPO
Sprinklr – $293 Million IPO
Centessa Pharmaceuticals – $380 Million IPO
LAVA Therapeutics – $107 Million IPO
Gamida Cell Closes $75 Million Financing With Highbridge Capital Management
Advises Anchiano Therapeutics Ltd on its reverse-merger with Chemomab
Orphazyme – $84 Million IPO
COMPASS Pathways – $147 Million IPO
PolyPid – $69 Million IPO
Calliditas Therapeutics - $90 Million IPO
Bavarian Nordic - DKK$2.7 Billion Rights Issue
Shake Shack - $215 Million Combined Secondary Offerings
Fangdd $78 Million – IPO
Applied Therapeutics $40 Million IPO
NextCure – $86 Million IPO
Neuronetics – $108 Million IPO
Gamida Cell – $50 Million IPO
AGNC Closes $507.2 Million Mortgage REIT Equity Offering
Underwriters: $1 billion Mobileye IPO
Semiconductor Developer Aquantia Closes $71 Million IPO
Zealand Pharma – $89 Million IPO
UroGen – $66.9 Million IPO
Selecta Biosciences – $74 Million IPO
Translate Bio – $122 Million IPO
Inotek Pharmaceuticals – $50 Million Follow-On
Syndax – $58 Million IPO
Arbor Realty Trust Closes $77.9 Million Mortgage REIT Equity Offering
Underwriters: $58 million Syndax IPO